Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 11, 2012 Filed Sep 12, 2012 21:25 UTC |
BURKE RICHARD TDirector
|
Exercise / conversionCommon Stock | 10,000 | $22.12 | $221,175.00 |
DisclosureSEC source: 0001209191-12-045301 · doc4.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,510,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2012 Filed Sep 10, 2012 20:32 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Exercise / conversionStock Appreciation Rights · Derivative | 28,280 | $0.00 Strike: $29.74 | $0.00 |
DisclosureSEC source: 0001209191-12-044878 · doc4.xml · derivative · entry 11 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,280 Underlying: Common Stock · 28,280 shares Expires 2019-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013. Read SEC document |
| September 07, 2012 Filed Sep 10, 2012 20:32 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Exercise / conversionStock Appreciation Rights · Derivative | 32,275 | $0.00 Strike: $33.94 | $0.00 |
DisclosureSEC source: 0001209191-12-044878 · doc4.xml · derivative · entry 10 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,275 shares Expires 2018-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on June 5 from the years 2009 through 2012. Read SEC document |
| September 07, 2012 Filed Sep 10, 2012 20:32 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
SaleCommon Stock | 12,229 | $54.95 | $671,946.86 |
DisclosureSEC source: 0001209191-12-044878 · doc4.xml · nonDerivative · entry 9 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Indirect · by Insurance Trust Disclosed balance after: 0 F4 · price: This transaction was executed in multiple trades ranging from $54.91 to $55.02 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| September 07, 2012 Filed Sep 10, 2012 20:32 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
SaleCommon Stock | 49,606 | $54.91 | $2,723,939.87 |
DisclosureSEC source: 0001209191-12-044878 · doc4.xml · nonDerivative · entry 8 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,096.9693 F3 · price: This transaction was executed in multiple trades ranging from $54.88 to $54.985 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| September 07, 2012 Filed Sep 10, 2012 20:32 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Tax withholdingCommon Stock | 20,856 | $54.89 | $1,144,785.84 |
DisclosureSEC source: 0001209191-12-044878 · doc4.xml · nonDerivative · entry 7 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,702.9693 Read SEC document |
| September 07, 2012 Filed Sep 10, 2012 20:32 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Exercise / conversionCommon Stock | 28,280 | $29.74 | $841,047.20 |
DisclosureSEC source: 0001209191-12-044878 · doc4.xml · nonDerivative · entry 6 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,558.9693 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2012 Filed Sep 10, 2012 20:32 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Tax withholdingCommon Stock | 25,217 | $54.89 | $1,384,161.13 |
DisclosureSEC source: 0001209191-12-044878 · doc4.xml · nonDerivative · entry 5 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,278.9693 Read SEC document |
| September 07, 2012 Filed Sep 10, 2012 20:32 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Exercise / conversionCommon Stock | 32,275 | $33.94 | $1,095,413.50 |
DisclosureSEC source: 0001209191-12-044878 · doc4.xml · nonDerivative · entry 4 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,495.9693 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2012 Filed Sep 10, 2012 20:32 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
SaleCommon Stock | 2,771 | $55.03 | $152,479.82 |
DisclosureSEC source: 0001209191-12-044878 · doc4.xml · nonDerivative · entry 3 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,220.9693 F2 · price: This transaction was executed in multiple trades ranging from $55.00 to $55.06 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 27, 2012 Filed Aug 28, 2012 21:01 UTC |
BALLARD WILLIAM C JRDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $22.12 | $0.00 |
DisclosureSEC source: 0001209191-12-043441 · doc4.xml · derivative · entry 3 BALLARD WILLIAM C JR · CIK 0001024398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2012-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2012 Filed Aug 28, 2012 21:01 UTC |
BALLARD WILLIAM C JRDirector
|
SaleCommon Stock | 10,000 | $54.96 | $549,620.00 |
DisclosureSEC source: 0001209191-12-043441 · doc4.xml · nonDerivative · entry 2 BALLARD WILLIAM C JR · CIK 0001024398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,135 F1 · price: This transaction was executed in multiple trades ranging from $54.92 to $54.975 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 27, 2012 Filed Aug 28, 2012 21:01 UTC |
BALLARD WILLIAM C JRDirector
|
Exercise / conversionCommon Stock | 10,000 | $22.12 | $221,175.00 |
DisclosureSEC source: 0001209191-12-043441 · doc4.xml · nonDerivative · entry 1 BALLARD WILLIAM C JR · CIK 0001024398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,135 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2012 Filed Aug 3, 2012 21:10 UTC |
BAER RICHARD NEVP & Chief Legal Officer
|
Tax withholdingCommon Stock | 4,608 | $51.10 | $235,468.80 |
DisclosureSEC source: 0001209191-12-040272 · doc4.xml · nonDerivative · entry 1 BAER RICHARD N · CIK 0001241852 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,571.479 Read SEC document |
| July 02, 2012 Filed Jul 3, 2012 20:48 UTC |
BALLARD WILLIAM C JRDirector
|
GrantCommon Stock | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-036983 · doc4.xml · nonDerivative · entry 1 BALLARD WILLIAM C JR · CIK 0001024398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,135 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| July 02, 2012 Filed Jul 3, 2012 20:48 UTC |
BURKE RICHARD TDirector
|
GrantCommon Stock | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-036986 · doc4.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500,075 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| July 02, 2012 Filed Jul 3, 2012 20:49 UTC |
DARRETTA ROBERT JDirector
|
GrantCommon Stock | 1,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-036988 · doc4.xml · nonDerivative · entry 1 DARRETTA ROBERT J · CIK 0001188999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,011 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| July 02, 2012 Filed Jul 3, 2012 20:49 UTC |
HOOPER MICHELE JDirector
|
GrantCommon Stock | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-036990 · doc4.xml · nonDerivative · entry 1 HOOPER MICHELE J · CIK 0001201723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,555 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| July 02, 2012 Filed Jul 3, 2012 20:50 UTC |
LAWSON RODGER ADirector
|
GrantCommon Stock | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-036993 · doc4.xml · nonDerivative · entry 1 LAWSON RODGER A · CIK 0001187442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,495 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| July 02, 2012 Filed Jul 3, 2012 20:50 UTC |
LEATHERDALE DOUGLAS WDirector
|
GrantCommon Stock | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-036994 · doc4.xml · nonDerivative · entry 1 LEATHERDALE DOUGLAS W · CIK 0001024367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 917,210 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| July 02, 2012 Filed Jul 3, 2012 20:51 UTC |
RENWICK GLENN MDirector
|
GrantCommon Stock | 1,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-036995 · doc4.xml · nonDerivative · entry 1 RENWICK GLENN M · CIK 0001198119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,711 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| July 02, 2012 Filed Jul 3, 2012 20:52 UTC |
Shine Kenneth IrwinDirector
|
GrantCommon Stock | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-036996 · doc4.xml · nonDerivative · entry 1 Shine Kenneth Irwin · CIK 0001455025 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,131 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| July 02, 2012 Filed Jul 3, 2012 20:52 UTC |
WILENSKY GAIL RDirector
|
GrantCommon Stock | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-036997 · doc4.xml · nonDerivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,025 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| June 22, 2012 Filed Jun 25, 2012 21:39 UTC |
BAER RICHARD NEVP & Chief Legal Officer
|
GrantCommon Stock | 258.73 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035238 · doc4.xml · nonDerivative · entry 1 BAER RICHARD N · CIK 0001241852 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,179.479 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| June 22, 2012 Filed Jun 25, 2012 21:40 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
GrantCommon Stock | 503.415 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035239 · doc4.xml · nonDerivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,727.701 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| June 22, 2012 Filed Jun 25, 2012 21:41 UTC |
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
|
GrantCommon Stock | 445.343 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035241 · doc4.xml · nonDerivative · entry 1 HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,735,442.574 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| June 22, 2012 Filed Jun 25, 2012 21:41 UTC |
RANGEN ERIC SSr VP & Chief Acctg Officer
|
GrantCommon Stock | 63.623 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035242 · doc4.xml · nonDerivative · entry 1 RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,986.208 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| June 22, 2012 Filed Jun 25, 2012 21:42 UTC |
RENFRO LARRY CEVP, UHG and CEO, Optum
|
GrantCommon Stock | 503.415 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035243 · doc4.xml · nonDerivative · entry 1 RENFRO LARRY C · CIK 0001235046 · EVP, UHG and CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,091.459 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| June 22, 2012 Filed Jun 25, 2012 21:42 UTC |
Sweere LoriEVP, Human Capital
|
GrantCommon Stock | 127.243 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035245 · doc4.xml · nonDerivative · entry 1 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,992.899 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| June 22, 2012 Filed Jun 25, 2012 21:43 UTC |
WICHMANN DAVID SEVP & CFO, Pres UHG Operations
|
GrantCommon Stock | 503.415 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035246 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · EVP & CFO, Pres UHG Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,121.641 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| June 22, 2012 Filed Jun 25, 2012 21:44 UTC |
BALLARD WILLIAM C JRDirector
|
GrantCommon Stock | 41 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035248 · doc4.xml · nonDerivative · entry 1 BALLARD WILLIAM C JR · CIK 0001024398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,468 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. Read SEC document |
| June 22, 2012 Filed Jun 25, 2012 21:45 UTC |
BURKE RICHARD TDirector
|
GrantCommon Stock | 41 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035250 · doc4.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,499,408 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. Read SEC document |
| June 22, 2012 Filed Jun 25, 2012 21:45 UTC |
DARRETTA ROBERT JDirector
|
GrantCommon Stock | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035251 · doc4.xml · nonDerivative · entry 1 DARRETTA ROBERT J · CIK 0001188999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,789 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. Read SEC document |
| June 22, 2012 Filed Jun 25, 2012 21:46 UTC |
HOOPER MICHELE JDirector
|
GrantCommon Stock | 41 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035252 · doc4.xml · nonDerivative · entry 1 HOOPER MICHELE J · CIK 0001201723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,888 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. Read SEC document |
| June 22, 2012 Filed Jun 25, 2012 21:47 UTC |
LAWSON RODGER ADirector
|
GrantCommon Stock | 36 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035254 · doc4.xml · nonDerivative · entry 1 LAWSON RODGER A · CIK 0001187442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,828 F1 · shares: Represents dividend equivalents paid on outstanding deferred stock units. Read SEC document |
| June 22, 2012 Filed Jun 25, 2012 21:47 UTC |
LEATHERDALE DOUGLAS WDirector
|
GrantCommon Stock | 41 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035255 · doc4.xml · nonDerivative · entry 2 LEATHERDALE DOUGLAS W · CIK 0001024367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 916,543 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. Read SEC document |
| June 22, 2012 Filed Jun 25, 2012 21:48 UTC |
RENWICK GLENN MDirector
|
GrantCommon Stock | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035256 · doc4.xml · nonDerivative · entry 1 RENWICK GLENN M · CIK 0001198119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,489 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. Read SEC document |
| June 22, 2012 Filed Jun 25, 2012 21:49 UTC |
Shine Kenneth IrwinDirector
|
GrantCommon Stock | 48 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035258 · doc4.xml · nonDerivative · entry 1 Shine Kenneth Irwin · CIK 0001455025 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,464 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. Read SEC document |
| June 22, 2012 Filed Jun 25, 2012 21:49 UTC |
WILENSKY GAIL RDirector
|
GrantCommon Stock | 41 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035259 · doc4.xml · nonDerivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,358 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. Read SEC document |
| June 20, 2012 Filed Jun 25, 2012 21:47 UTC |
LEATHERDALE DOUGLAS WDirector
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-035255 · doc4.xml · nonDerivative · entry 1 LEATHERDALE DOUGLAS W · CIK 0001024367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 916,502 Read SEC document |
| June 19, 2012 Filed Jun 20, 2012 21:21 UTC |
Sweere LoriEVP, Human Capital
|
Exercise / conversionStock Appreciation Rights · Derivative | 25,455 | $0.00 Strike: $33.94 | $0.00 |
DisclosureSEC source: 0001209191-12-034729 · doc4.xml · derivative · entry 4 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,455 Underlying: Common Stock · 25,455 shares Expires 2018-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on June 5 from the years 2009 through 2012. Read SEC document |
| June 19, 2012 Filed Jun 20, 2012 21:21 UTC |
Sweere LoriEVP, Human Capital
|
SaleCommon Stock | 6,254 | $60.12 | $375,991.73 |
DisclosureSEC source: 0001209191-12-034729 · doc4.xml · nonDerivative · entry 3 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,865.656 F1 · price: This transaction was executed in multiple trades ranging from $60.111 to $60.122 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 19, 2012 Filed Jun 20, 2012 21:21 UTC |
Sweere LoriEVP, Human Capital
|
Tax withholdingCommon Stock | 19,201 | $59.42 | $1,140,923.42 |
DisclosureSEC source: 0001209191-12-034729 · doc4.xml · nonDerivative · entry 2 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,119.656 Read SEC document |
| June 19, 2012 Filed Jun 20, 2012 21:21 UTC |
Sweere LoriEVP, Human Capital
|
Exercise / conversionCommon Stock | 25,455 | $33.94 | $863,942.70 |
DisclosureSEC source: 0001209191-12-034729 · doc4.xml · nonDerivative · entry 1 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,320.656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2012 Filed Jun 20, 2012 21:22 UTC |
WILENSKY GAIL RDirector
|
Exercise / conversionNon-qualified stock option (right to buy) · Derivative | 880 | $0.00 Strike: $23.19 | $0.00 |
DisclosureSEC source: 0001209191-12-034730 · doc4.xml · derivative · entry 5 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 880 shares Expires 2013-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2012 Filed Jun 20, 2012 21:22 UTC |
WILENSKY GAIL RDirector
|
Exercise / conversionNon-qualified stock option (right to buy) · Derivative | 10,000 | $0.00 Strike: $22.82 | $0.00 |
DisclosureSEC source: 0001209191-12-034730 · doc4.xml · derivative · entry 4 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2013-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2012 Filed Jun 20, 2012 21:22 UTC |
WILENSKY GAIL RDirector
|
SaleCommon Stock | 10,880 | $60.48 | $658,034.37 |
DisclosureSEC source: 0001209191-12-034730 · doc4.xml · nonDerivative · entry 3 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,317 F1 · price: This transaction was executed in multiple trades ranging from $60.47 to $60.50 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 19, 2012 Filed Jun 20, 2012 21:22 UTC |
WILENSKY GAIL RDirector
|
Exercise / conversionCommon Stock | 880 | $23.19 | $20,407.20 |
DisclosureSEC source: 0001209191-12-034730 · doc4.xml · nonDerivative · entry 2 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2012 Filed Jun 20, 2012 21:22 UTC |
WILENSKY GAIL RDirector
|
Exercise / conversionCommon Stock | 10,000 | $22.82 | $228,200.00 |
DisclosureSEC source: 0001209191-12-034730 · doc4.xml · nonDerivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2012 Filed Jun 18, 2012 20:36 UTC |
BURKE RICHARD TDirector
|
SaleCommon Stock | 31,920 | $58.51 | $1,867,680.70 |
DisclosureSEC source: 0001209191-12-034293 · doc4.xml · nonDerivative · entry 2 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,499,367 F1 · price: This transaction was executed in multiple trades ranging from $58.50 to $58.72 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.